Top-News
Pharmazeutika Deutschland

Evotec SE ADR News

Aktie
WKN:  A0QZ3J ISIN:  US30050E1055 US-Symbol:  EVO
4,40 €
+0,08 €
+1,85%
18.07.24
Handeln Depot/Watchlist
Aktienanzahl *
354,00 Mio.
Marktkapitalisierung *
1,53 Mrd. €
Streubesitz
62,67%
Faktor
0.5
Originalaktie
DE0005664809
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 26.06.2024

Evotec SE ADR News

18.04.24 - PR Newswire
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS PR Newswire
28.03.24 - PR Newswire
Evolution enters Delaware through Rush Street Interactive
Evolution enters Delaware through Rush Street Interactive PR Newswire
21.02.24 - PR Newswire
Evolution and Caesars Digital sign strategic agreement to expand partnership throughout North America
Evolution and Caesars Digital sign strategic agreement to expand partnership throughout North America PR Newswire
20.02.24 - PR Newswire
New Jersey Division of Gaming Enforcement has closed its investigation of Evolution AB with no further action
New Jersey Division of Gaming Enforcement has closed its investigation of Evolution AB with no further action PR Newswire
09.02.24 - PR Newswire
The Gross Law Firm Notifies Shareholders of Evolution AB (publ)(EVVTY) of a Class Action Lawsuit and an Upcoming Deadline
The Gross Law Firm Notifies Shareholders of Evolution AB (publ)(EVVTY) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire
12.12.23 - PR Newswire
Landmark US launch for Crazy Time, Evolution's world #1 online live game show
Landmark US launch for Crazy Time, Evolution's world #1 online live game show PR Newswire
23.11.23 - PR Newswire
The board of directors of Evolution AB (publ) has resolved on acquisitions of own shares
The board of directors of Evolution AB (publ) has resolved on acquisitions of own shares PR Newswire
14.06.21 - PR Newswire
CEBINA announces the launch of Danube Labs, a partnership with Evotec to develop cutting edge biotechnology projects sourced from Central and Eastern European Universities and Research Institutions
CEBINA announces the launch of Danube Labs, a partnership with Evotec to develop cutting edge biotechnology projects sourced from Central and Eastern European Universities ...
24.06.20 - PR Newswire
Samsara BioCapital, Evotec and KCK Launch Autobahn Labs, a Novel Early Stage Drug Discovery Incubator
Samsara BioCapital, Evotec and KCK Launch Autobahn Labs, a Novel Early Stage Drug Discovery Incubator Autobahn Labs and UCLA Announce Strategic Collaboration PR Newswire
02.04.20 - PR Newswire
Evotec Expands its iPSC-Based Cell Therapy Platform EVOcells Through Licensing Agreement with panCELLa
Evotec Expands its iPSC-​Based Cell Therapy Platform EVOcells Through Licensing Agreement with panCELLa Canada NewsWire
25.03.20 - DGAP
Stimmrechtsanteile: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: Evotec SE Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-...
13.02.20 - DGAP
Stimmrechtsanteile: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: Evotec SE Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-...
11.02.20 - DGAP
Stimmrechtsanteile: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: Evotec SE Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-...
23.01.20 - PR Newswire
Evotec and Indivumed Announce Second Joint Drug Discovery Program
Evotec and Indivumed Announce Second Joint Drug Discovery Program Partnership Aims to Replicate Successful Milestone Achievement from Revolutionary Joint Drug Discovery ...
21.01.20 - DGAP
Stimmrechtsanteile: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: Evotec SE Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-...
13.01.20 - DGAP
Stimmrechtsanteile: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: Evotec SE Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-...
13.01.20 - DGAP
Stimmrechtsanteile: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: Evotec SE Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-...
08.01.20 - DGAP
Stimmrechtsanteile: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: Evotec SE Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-...
22.11.19 - DGAP
Stimmrechtsanteile: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: Evotec SE Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-...
13.11.19 - DGAP
Stimmrechtsanteile: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: Evotec SE Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-...

Newssuche

Videos

newspaper
18.07.24 -10,66%
Technical Trading: Gold ausgebrochen - Long Chance
Gold Long Typ: Turbo Open End WKN: JB3ZLF Hebel: 5,5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »